Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
10.93
-0.01 (-0.09%)
At close: Dec 5, 2025, 4:00 PM EST
10.94
+0.01 (0.09%)
After-hours: Dec 5, 2025, 7:24 PM EST
Evoke Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -5.23 | -5.35 | -7.79 | -8.22 | -8.54 | -13.15 | |
| Stock-Based Compensation | 0.55 | 0.77 | 1.13 | 1.46 | 1.88 | 1.63 | |
| Other Operating Activities | 0.57 | 0.52 | 0.63 | 0.04 | -0.08 | - | |
| Change in Accounts Receivable | -1.17 | -1.75 | -0.05 | -0.33 | -0.27 | - | |
| Change in Inventory | -0.11 | 0.03 | -0.19 | -0.1 | 0.02 | -0.24 | |
| Change in Accounts Payable | 1.93 | 0.75 | 0.66 | 0.06 | -0.53 | 0.24 | |
| Change in Other Net Operating Assets | 0.12 | -0.44 | 0.64 | 0.51 | -4.84 | 4.89 | |
| Operating Cash Flow | -3.32 | -5.46 | -4.98 | -6.6 | -12.35 | -6.63 | |
| Short-Term Debt Issued | - | - | - | - | - | 0.1 | |
| Long-Term Debt Issued | - | - | - | - | - | 5 | |
| Total Debt Issued | - | - | - | - | - | 5.1 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | 5.1 | |
| Issuance of Common Stock | 3.55 | 14.74 | - | 7.44 | 14.74 | 3.93 | |
| Repurchase of Common Stock | - | -0 | - | - | - | - | |
| Other Financing Activities | 0.02 | -0.43 | -0.12 | -0.15 | -1.31 | - | |
| Financing Cash Flow | 3.56 | 14.32 | -0.12 | 7.29 | 13.43 | 9.04 | |
| Net Cash Flow | 0.24 | 8.86 | -5.1 | 0.7 | 1.08 | 2.41 | |
| Levered Free Cash Flow | -1.86 | -3.67 | -0.91 | -4.05 | -9.63 | -1.81 | |
| Unlevered Free Cash Flow | -1.54 | -3.36 | -0.6 | -3.74 | -9.32 | -1.74 | |
| Change in Working Capital | 0.77 | -1.4 | 1.05 | 0.13 | -5.62 | 4.9 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.